Literature DB >> 8626986

Trial of a "credit card" asthma self-management plan in a high-risk group of patients with asthma.

W D'Souza1, C Burgess, M Ayson, J Crane, N Pearce, R Beasley.   

Abstract

BACKGROUND: The "credit card" asthma self-management plan provides the adult asthmatic patient with simple guidelines for the self-management of asthma, which are based on the self-assessment of peak expiratory flow rate recordings and symptoms.
OBJECTIVE: The study was a trial of the clinical efficacy of the credit card plan in a high-risk group of asthmatic patients.
METHODS: In this "before-and-after" trial, patients discharged from the emergency department of Wellington Hospital, after treatment for severe asthma were invited to attend a series of hospital outpatient clinics at which the credit card plan was introduced. Questionnaires were used to compare markers of asthma morbidity, requirement for emergency medical care, and medication use during the 6-month period before and after intervention with the credit card plan.
RESULTS: Of the 30 patients with asthma who attended the first outpatient clinic, 26 (17 women and 9 men) completed the program. In these 26 participants, there was a reduction in both morbidity and requirement for acute medical services: specifically, the proportion waking with asthma more than once a week decreased from 65% to 23% (p = 0.005) and the proportion visiting the emergency department for treatment of severe asthma decreased from 58% to 15% (p = 0.004). The patients attending the clinics commented favorably on the plan, in particular on its usefulness as an educational tool for monitoring and treating their asthma.
CONCLUSIONS: Although the interpretation of this study is limited by the lack of a randomized control group, the findings are consistent with other evidence that the credit card asthma self-management plan can be an effective and acceptable system for improving asthma care in a high-risk group of adult patients with asthma.

Entities:  

Mesh:

Year:  1996        PMID: 8626986     DOI: 10.1016/s0091-6749(96)70262-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma.

Authors:  A Sonia Buist; William M Vollmer; Sandra R Wilson; E Ann Frazier; Arthur D Hayward
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

2.  Managing one's body using self-management techniques: practicing autonomy.

Authors:  D Willems
Journal:  Theor Med Bioeth       Date:  2000-01

Review 3.  Objectives, methods and content of patient education programmes for adults with asthma: systematic review of studies published between 1979 and 1998.

Authors:  P Sudre; S Jacquemet; C Uldry; T V Perneger
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 4.  Personalised asthma action plans for adults with asthma.

Authors:  Timothy L Gatheral; Alison Rushton; David Jw Evans; Caroline A Mulvaney; Nathan R Halcovitch; Gemma Whiteley; Fiona Jr Eccles; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2017-04-10

Review 5.  Drug treatment of asthma in the 1990s: achievements and new strategies.

Authors:  A Tavakkoli; P J Rees
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

6.  Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid.

Authors:  J Garrett; S Williams; C Wong; D Holdaway
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

Review 7.  Adding non-randomised studies to a Cochrane review brings complementary information for healthcare stakeholders: an augmented systematic review and meta-analysis.

Authors:  Chantal Arditi; Bernard Burnand; Isabelle Peytremann-Bridevaux
Journal:  BMC Health Serv Res       Date:  2016-10-21       Impact factor: 2.655

8.  Impact of non-drug therapies on asthma control: A systematic review of the literature.

Authors:  Matthieu Schuers; Anthony Chapron; Hugo Guihard; Tiphanie Bouchez; David Darmon
Journal:  Eur J Gen Pract       Date:  2019-03-08       Impact factor: 1.904

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.